Orthofix Medical Inc. (OFIX) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OFIX Revenue Growth
Revenue Breakdown (FY 2025)
OFIX's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
OFIX Revenue Analysis (2014–2025)
As of May 8, 2026, Orthofix Medical Inc. (OFIX) generated trailing twelve-month (TTM) revenue of $825.4 million, reflecting modest growth of +1.6% year-over-year. The most recent quarter (Q1 2026) recorded $196.7 million in revenue, down 10.6% sequentially.
Looking at the longer-term picture, OFIX's 5-year compound annual growth rate (CAGR) stands at +15.1%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $822.3 million in 2025, representing a new all-time high.
Revenue diversification analysis shows OFIX's business is primarily driven by Global Spine (100%). With over half of revenue concentrated in Global Spine, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), ATEC (-7.4% YoY), and XTNT (+16.9% YoY), OFIX has underperformed the peer group in terms of revenue growth. Compare OFIX vs NVCR →
OFIX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OFIXCurrent | $825M | +1.6% | +15.1% | -8.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ATEC | $764M | -7.4% | +39.5% | -10.7% | |
 XTNT | $117M | +16.9% | +12.6% | -10.3% | |
 NVAX | $1.1B | -52.5% | +118.8% | 50.1% | |
 GMED | $2.9B | +23.5% | +30.1% | 16.3% |
OFIX Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $822.3M | +2.9% | $551.7M | 67.1% | $-68,471,000 | -8.3% |
| 2024 | $799.5M | +7.1% | $545.9M | 68.3% | $-84,619,000 | -10.6% |
| 2023 | $746.6M | +62.1% | $486.3M | 65.1% | $-139,110,000 | -18.6% |
| 2022 | $460.7M | -0.8% | $337.2M | 73.2% | $-13,268,000 | -2.9% |
| 2021 | $464.5M | +14.2% | $349.6M | 75.3% | $-8,315,000 | -1.8% |
| 2020 | $406.6M | -11.6% | $304.7M | 74.9% | $-6,266,000 | -1.5% |
| 2019 | $460.0M | +1.5% | $359.3M | 78.1% | $-18,784,000 | -4.1% |
| 2018 | $453.0M | +4.4% | $356.4M | 78.7% | $30.1M | 6.6% |
| 2017 | $433.8M | +5.9% | $340.8M | 78.6% | $40.8M | 9.4% |
| 2016 | $409.8M | +3.4% | $321.9M | 78.6% | $21.1M | 5.1% |
See OFIX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OFIX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OFIX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOFIX — Frequently Asked Questions
Quick answers to the most common questions about buying OFIX stock.
Is OFIX's revenue growth accelerating or slowing?
OFIX revenue growth slowed to +1.6%, below the 5-year CAGR of +15.1%. TTM revenue is $825M. The deceleration marks a shift from historical growth rates.
What is OFIX's long-term revenue growth rate?
Orthofix Medical Inc.'s 5-year revenue CAGR of +15.1% reflects the variable expansion pattern. Current YoY growth of +1.6% is near this long-term average.
How is OFIX's revenue distributed by segment?
OFIX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.